Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liang-In Lin

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
European Journal of Haematology|April 7, 2018
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patientsFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
Hemasphere|December 1, 2022
Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry StudyChi-Yuan Yao, Andreas Agathangelidis, Shih-Sung Chuang, et al.
Blood Cancer Journal|September 8, 2018
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemiaFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
American Journal of Hematology|March 2, 2023
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemiaMin-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, et al.
Blood Cancer Journal|May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutationsSao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
Blood Cancer Journal|January 22, 2024
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutationsFeng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
Oncotarget|January 27, 2016
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemiaHsin-An Hou, Chieh-Yu Liu, Yuan-Yeh Kuo, et al.
Blood|November 15, 2011
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implicationsHsin-An Hou, Yuan-Yeh Kuo, Chieh-Yu Liu, et al.
Annals of Hematology|September 22, 2014
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolutionHsin-An Hou, Yun-Chu Lin, Yuan-Yeh Kuo, et al.
Bone Marrow Transplantation|October 21, 2021
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remissionFeng-Ming Tien, Cheng-Hong Tsai, Sheng-Chuan Huang, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
European Journal of Haematology|April 7, 2018
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patientsFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
Hemasphere|December 1, 2022
Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry StudyChi-Yuan Yao, Andreas Agathangelidis, Shih-Sung Chuang, et al.
Blood Cancer Journal|September 8, 2018
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemiaFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
American Journal of Hematology|March 2, 2023
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemiaMin-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, et al.
Blood Cancer Journal|May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutationsSao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
Blood Cancer Journal|January 22, 2024
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutationsFeng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
Oncotarget|January 27, 2016
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemiaHsin-An Hou, Chieh-Yu Liu, Yuan-Yeh Kuo, et al.
Blood|November 15, 2011
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implicationsHsin-An Hou, Yuan-Yeh Kuo, Chieh-Yu Liu, et al.
Annals of Hematology|September 22, 2014
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolutionHsin-An Hou, Yun-Chu Lin, Yuan-Yeh Kuo, et al.
Bone Marrow Transplantation|October 21, 2021
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remissionFeng-Ming Tien, Cheng-Hong Tsai, Sheng-Chuan Huang, et al.
Pageof 9